Research & Development

Can Genetic Testing Prevent Heart Attacks and Strokes?
Research & Development Can Genetic Testing Prevent Heart Attacks and Strokes?

Every year, millions of lives are cut short or forever altered by heart attacks and strokes, which stand as the leading causes of death across the globe, often striking with little to no warning, leaving families grappling with loss and survivors facing long, challenging recoveries. However,

Safer Treatment Paths for Kids with Medulloblastoma Unveiled
Research & Development Safer Treatment Paths for Kids with Medulloblastoma Unveiled

Every year, hundreds of children are diagnosed with medulloblastoma, a highly aggressive brain tumor that ranks as one of the most common malignant brain cancers in pediatric patients, leaving families grappling with not only the fear of survival but also the long-term consequences of harsh

MIT Unveils New Vaccine Targets to Fight Tuberculosis
Research & Development MIT Unveils New Vaccine Targets to Fight Tuberculosis

What happens when a disease, hidden in plain sight, claims over a million lives each year, yet remains stubbornly resistant to modern medicine? Tuberculosis (TB), caused by Mycobacterium tuberculosis , stands as one of humanity's oldest and deadliest foes, striking hardest in vulnerable communities

How Do Early and Late Autism Diagnoses Differ Genetically?
Research & Development How Do Early and Late Autism Diagnoses Differ Genetically?

Autism Spectrum Disorder (ASD) has traditionally been understood as a condition manifesting in early childhood, yet a pioneering study from the University of Cambridge is turning this perspective on its head with revelations about the genetic and developmental differences tied to the timing of

Can At-Home Urine Tests Revolutionize Early Cancer Detection?
Research & Development Can At-Home Urine Tests Revolutionize Early Cancer Detection?

Imagine a future where detecting cancer at its earliest stage is as straightforward as swallowing a pill and analyzing a urine sample in the privacy of one’s home, without the need for intimidating hospital visits or invasive procedures. This transformative vision is taking shape through a

PTGES3 Emerges as Key Target in Prostate Cancer Treatment
Research & Development PTGES3 Emerges as Key Target in Prostate Cancer Treatment

In a significant leap forward for prostate cancer research, a recent study published in Nature Genetics on November 5 has spotlighted PTGES3 (Prostaglandin E Synthase 3) as a pivotal regulator of the androgen receptor (AR), a protein deeply implicated in the disease’s progression. Conducted by

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later